KBC Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$462K Hold
8,837
﹤0.01% 795
2025
Q4
$520K Hold
8,837
﹤0.01% 717
2025
Q3
$492K Hold
8,837
﹤0.01% 706
2025
Q2
$455K Sell
8,837
-4,605
-34% -$231K ﹤0.01% 715
2025
Q1
$788K Sell
13,442
-5,601
-29% -$380K ﹤0.01% 683
2024
Q4
$1.37M Hold
19,043
﹤0.01% 737
2024
Q3
$1.52M Buy
19,043
+5,601
+42% +$421K ﹤0.01% 645
2024
Q2
$963K Sell
13,442
-6,223
-32% -$458K ﹤0.01% 668
2024
Q1
$1.38M Sell
19,665
-22,545
-53% -$1.61M ﹤0.01% 635
2023
Q4
$3.26M Sell
42,210
-4,947
-10% -$326K 0.01% 531
2023
Q3
$3.21M Sell
47,157
-1,229
-3% -$97.1K 0.01% 513
2023
Q2
$3.95M Buy
48,386
+32,516
+205% +$2.61M 0.02% 495
2023
Q1
$1.18M Sell
15,870
-1,569
-9% -$121K 0.01% 710
2022
Q4
$1.45M Buy
17,439
+7,163
+70% +$569K 0.01% 652
2022
Q3
$729K Sell
10,276
-60
-0.6% -$5.18K ﹤0.01% 706
2022
Q2
$896K Sell
10,336
-3,664
-26% -$343K ﹤0.01% 678
2022
Q1
$1.52M Buy
14,000
+6,412
+85% +$662K 0.01% 631
2021
Q4
$981K Sell
7,588
-227,948
-97% -$27.9M ﹤0.01% 723
2021
Q3
$28.5M Buy
235,536
+185,568
+371% +$22.6M 0.1% 208
2021
Q2
$5.62M Buy
+49,968
New +$5.26M 0.01% 594

Other funds holding TECH

KBC Group's TECH Position: Q1 2026 in Review

KBC Group held its Bio-Techne (TECH) position steady in Q1 2026 at 8,837 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #795.

KBC Group first reported a position in TECH in Q2 2021 and has held it in 20 quarters since. The position peaked at $28.5M in Q3 2021. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • KBC Group held 8,837 shares of Bio-Techne worth $462K as of Q1 2026.
  • KBC Group left its Bio-Techne share count unchanged in Q1 2026.
  • Bio-Techne made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #795 holding.
  • KBC Group first reported a position in Bio-Techne in Q2 2021 and has held it in 20 quarters since.
  • KBC Group's Bio-Techne position peaked at $28.5M in Q3 2021.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.